                         SEQUENCE LISTING

<110>  Mallinckrodt Inc.
       Rajagopalan, Raghavan
       Neumann, William, L.
       Dorshow, Richard, B.
 
<120>  INTEGRATED PHOTOACTIVE PEPTIDES AND USES THEREOF

<130>  H-MI-00104

<160>  21    

<170>  PatentIn version 3.4

<210>  1
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificially synthesized peptide

<400>  1

Pro Leu Ala Glu Ile Asp Gly Ile Glu Leu Thr Tyr 
1               5                   10          


<210>  2
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificially synthesized peptide

<400>  2

Ala Asn Ile Lys Leu Ser Val Gln Met Lys Leu 
1               5                   10      


<210>  3
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificially synthesized peptide

<400>  3

Ser Val Gln Met Lys Leu 
1               5       


<210>  4
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificially synthesized peptide

<400>  4

Ile Lys Leu Ser Val Gln Met Lys Leu 
1               5                   


<210>  5
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificially synthesized peptide

<400>  5

Asn Ile Lys Leu Ser Val Gln Met Lys Leu 
1               5                   10  


<210>  6
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificially synthesized peptide

<400>  6

Asn Thr Phe Tyr Cys Cys Asp Leu Cys Cys Tyr Pro Ala Glu Ala Gly 
1               5                   10                  15      


Cys Asn 
        


<210>  7
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having a pyrazine side chain


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa=pyrazine

<400>  7

Asn Thr Phe Tyr Cys Cys Asp Leu Cys Cys Xaa Pro Ala Glu Ala Gly 
1               5                   10                  15      


Cys Asn 
        


<210>  8
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having an azulene side chain


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa=azulene

<400>  8

Asn Thr Phe Tyr Cys Cys Asp Leu Cys Cys Xaa Pro Ala Glu Ala Gly 
1               5                   10                  15      


Cys Asn 
        


<210>  9
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having an azaazulene side chain


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa=azaazulene

<400>  9

Asn Thr Phe Tyr Cys Cys Asp Leu Cys Cys Xaa Pro Ala Glu Ala Gly 
1               5                   10                  15      


Cys Asn 
        


<210>  10
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificially synthesized peptide

<400>  10

Pro Leu Ala Glu Ile Asp Gly Ile Glu Leu Thr Tyr 
1               5                   10          


<210>  11
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having a pyrazine side chain


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa=pyrazine

<400>  11

Pro Leu Ala Glu Ile Asp Gly Ile Glu Leu Thr Xaa 
1               5                   10          


<210>  12
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having an azulene side chain


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa=azulene

<400>  12

Pro Leu Ala Glu Ile Asp Gly Ile Glu Leu Thr Xaa 
1               5                   10          


<210>  13
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having an azaazulene side chain


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa=azaazulene

<400>  13

Pro Leu Ala Glu Ile Asp Gly Ile Glu Leu Thr Xaa 
1               5                   10          


<210>  14
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificially synthesized peptide

<400>  14

Ala Asn Ile Lys Leu Ser Val Gln Met Lys Leu 
1               5                   10      


<210>  15
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having a pyrazine side chain


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa=pyrazine

<400>  15

Ala Asn Ile Lys Leu Ser Val Xaa Met Lys Leu 
1               5                   10      


<210>  16
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having an azulene side chain


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa=azulene

<400>  16

Ala Asn Ile Lys Leu Ser Val Xaa Met Lys Leu 
1               5                   10      


<210>  17
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having an azaazulene side chain


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa=azaazulene

<400>  17

Ala Asn Ile Lys Leu Ser Val Xaa Met Lys Leu 
1               5                   10      


<210>  18
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Artificially synthesized peptide

<400>  18

Ser Phe Phe Tyr Leu Arg Ser 
1               5           


<210>  19
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having a pyrazine side chain


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa=pyrazine

<400>  19

Ser Phe Phe Xaa Leu Arg Ser 
1               5           


<210>  20
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having an azulene side chain


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa=azulene

<400>  20

Ser Phe Phe Xaa Leu Arg Ser 
1               5           


<210>  21
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified amino acid residue having an azaazulene side chain


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa=azaazulene

<400>  21

Ser Phe Phe Xaa Leu Arg Ser 
1               5           


